0.00Open0.00Pre Close0 Volume0 Open Interest1.00Strike Price0.00Turnover1239.45%IV55.36%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.0479Delta0.0163Gamma2.99Leverage Ratio-0.0178Theta-0.0003Rho-0.14Eff Leverage0.0005Vega
Standard BioTools Stock Discussion
assay services, kits and related revenue in 2024; and
-- Ended the quarter with cash, cash equivalents, restricted cash and
short-term investments of $464 million, after accounting for $71 million
cash payments for merger-related expenses, settlement of year-end
operating accruals, debt retirement and completed stock buybacks.
2 MINUTES AGO, 8:00 AM EDT
VIA GLOBENEWSWIRE
Benzinga· 1 min ago
No comment yet